KANE BIOTECH INC (KNE.CA) Stock Income Statement
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.44M | 2.08M | 149.00K | 2.67M | 1.61M | |||
| Minority Interest Expense | 0.00 | 0.00 | 0.00 | -65.90K | 245.40K | |||
| Cost Of Goods | 1.57M | 1.21M | 39.50K | 1.26M | 1.04M | |||
| Gross Profit | 874.50K | 872.10K | 109.50K | 1.41M | 568.50K | |||
| Operating Expenses | 4.77M | 4.80M | 3.47M | 4.78M | 5.45M | |||
| Research and Development | 1.54M | 1.72M | 1.05M | 1.05M | 1.38M | |||
| Selling, General, and Administrative Expenses | 3.23M | 3.08M | 2.41M | 3.72M | 4.07M | |||
| Operating Income | -3.90M | -3.92M | -3.36M | -3.36M | -4.88M | |||
| Interest Income/Expense | -300.10K | -548.40K | -1.21M | -715.10K | -290.20K | |||
| Other Income/Expense | N/A | 0.00 | 3.80K | 254.90K | 323.80K | |||
| Income Before Taxes | -4.20M | -4.47M | -4.56M | -3.82M | -4.85M | |||
| Income Tax | N/A | -1.31M | N/A | N/A | N/A | |||
| Net Income | 6.23M | 6.10M | -5.03M | -3.89M | -4.60M | |||
| EBITDA | -3.68M | -3.70M | -3.12M | -3.10M | -4.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.05 | 0.04 | -0.04 | -0.03 | -0.04 | |||
| Statistics | ||||||||
| Gross Profit Margin | 35.82% | 41.91% | 73.49% | 52.96% | 35.36% | |||
| Profit Margin | 255.02% | 293.04% | -3378.59% | -145.78% | -286.39% | |||
| Operating Profit Margin | -159.57% | -188.52% | -2253.29% | -126.06% | -303.74% | |||
All data in CAD